Lintao Jiang

Title: Lintao Jiang: Innovator in Anti-Tubercular Drug Formulation

Introduction

Lintao Jiang is a notable inventor based in Fuyang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of anti-tubercular drugs. His innovative approach has led to advancements that enhance the stability and bioavailability of essential medications.

Latest Patents

Lintao Jiang holds a patent for an oral solid formulation of a compound anti-tubercular drug. This patent, which includes the preparation method, features a unique combination of active ingredients: rifampicin, isoniazid, pyrazinamide, and ethambutol hydrochloride. The formulation is designed as a coated tablet with a coated core or a coated three-layer tablet, ensuring that rifampicin and isoniazid do not come into direct contact. This innovative design not only improves the stability of the compound preparation but also enhances the bioavailability of rifampicin.

Career Highlights

Lintao Jiang is associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he continues to work on developing effective pharmaceutical solutions. His expertise in drug formulation has positioned him as a key player in the industry, contributing to the fight against tuberculosis.

Collaborations

Lintao Jiang collaborates with talented colleagues, including Maojian Gu and Qilan Zheng. Their combined efforts in research and development have fostered a productive environment for innovation in pharmaceutical formulations.

Conclusion

Lintao Jiang's contributions to the field of anti-tubercular drug formulation exemplify the impact of innovative thinking in pharmaceuticals. His work not only addresses critical health challenges but also sets a standard for future developments in drug formulation.